Clinical study on Qinghouyan lozenge in treatment of acute pharyngitis.
- Author:
Jiao-iiao YU
;
Zhen-yu XUAN
;
Yan RUAN
;
Hui-yong ZHANG
;
Ke-hua SHI
;
Yu GUO
- Publication Type:Journal Article
- MeSH:
Acute Disease;
Double-Blind Method;
Humans;
Medicine, Chinese Traditional;
Pharyngitis;
drug therapy
- From:
China Journal of Chinese Materia Medica
2015;40(2):351-355
- CountryChina
- Language:Chinese
-
Abstract:
To evaluate the clinical efficacy and safety of Qinghouyan lozenge in the treatment of acute pharyngitis due to Lung-heat and Yin-deficiency, and compare with Qinghouyan oral Liquid. Totally 144 subjects were enrolled and randomly divided into two groups (72 in the test group and 72 in the control group). The participants in the test group were given Qinghouyan lozenge for 5 days, and those in the control group were given Qinghouyan oral Liquid for 5 days. The effectiveness evaluation indexes were pharyngalgia/odynophagia disappearance rate, overall efficacy of TCM syndromes, TCM syndrome scores, and single syndrome and sign disappearance rate. During the test, the safety was evaluated by vital sign, lab examination indexes and adverse events. The results for the full analysis set showed that the couth disappearance rate, the incidence rate of TCM syndromes, and the throat/uvula congestion disappearance rate of the test group were higher than that of the control group (P < 0.05), with significant differences in the changes in syndrome scores between the two groups (P < 0.05). Altogether 3 adverse events were observed in the test group while 6 adverse events in the control group, without significant differences in the adverse event rate between the two groups (P < 0.05), serious abnormal laboratory examinations and vital signs. In conclusion, Qinghouyan lozenge has better efficacy in treatment of acute pharyngitis due to Lung-heat and Yin-deficiency than Qinghouyan oral liquid, with good safety.
